Literature DB >> 17987360

Specific pharmacokinetic interaction between lumefantrine and monodesbutyl-benflumetol in Plasmodium falciparum.

Peter Starzengruber1, Gunther Wernsdorfer, Maria Parizek, Chaiporn Rojanawatsirivet, Herwig Kollaritsch, Walther H Wernsdorfer.   

Abstract

The blood schizontocidal activity of lumefantrine, monodesbutyl-benflumetol (DBB) and a 999:1 combination of both compounds has been investigated in 26 fresh isolates of Plasmodium falciparum from northwestern Thailand, using the WHO standard protocol Mark II for determining the inhibition of schizont maturation. The geometric mean cut-off concentrations of schizont maturation (GMCOC) were 943.2 nM for lumefantrine, 146.3 nM for DBB and 182.2 nM for the 999:1 combination of lumefantrine and DBB. The EC(50) values were 27.3 nM for lumefantrine, 5.7 nM for DBB, and 16.5 nM for the combination, and the EC(90) values 163.1 nM for lumefantrine, 44.1 nM for DBB, and 78.3 nM for the combination. Despite the very low concentration in the combination, DBB exerted significant synergistic activity with lumefantrine that was strongest at the EC(90) and EC(99) levels. Correlation analysis indicates that DBB is the leading determinant for the activity of the combination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17987360     DOI: 10.1007/s00508-007-0861-9

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  15 in total

1.  Determination of a new antimalarial drug, benflumetol, in blood plasma by high-performance liquid chromatography.

Authors:  S M Mansor; V Navaratnam; N Yahaya; N K Nair; W H Wernsdorfer; P H Degen
Journal:  J Chromatogr B Biomed Appl       Date:  1996-07-12

2.  Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro.

Authors:  S T Mariga; J P Gil; W H Wernsdorfer; A Björkman
Journal:  Acta Trop       Date:  2005-03       Impact factor: 3.112

3.  Desbutyl-benflumetol, a novel antimalarial compound: in vitro activity in fresh isolates of Plasmodium falciparum from Thailand.

Authors:  H Noedl; T Allmendinger; S Prajakwong; G Wernsdorfer; W H Wernsdorfer
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  A method for testing for synergy with any number of agents.

Authors:  M C Berenbaum
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

5.  Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria.

Authors:  M V Vugt; P Wilairatana; B Gemperli; I Gathmann; L Phaipun; A Brockman; C Luxemburger; N J White; F Nosten; S Looareesuwan
Journal:  Am J Trop Med Hyg       Date:  1999-06       Impact factor: 2.345

Review 6.  Malaria at the turn from the 2nd to the 3rd millenium.

Authors:  Gunther Wernsdorfer; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2003       Impact factor: 1.704

Review 7.  Coartemether (artemether and lumefantrine): an oral antimalarial drug.

Authors:  Walther H Wernsdorfer
Journal:  Expert Rev Anti Infect Ther       Date:  2004-04       Impact factor: 5.091

Review 8.  Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices.

Authors:  Shunmay Yeung; Wirichada Pongtavornpinyo; Ian M Hastings; Anne J Mills; Nicholas J White
Journal:  Am J Trop Med Hyg       Date:  2004-08       Impact factor: 2.345

9.  Determination of benflumetol in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.

Authors:  M Y Zeng; Z L Lu; S C Yang; M Zhang; J Liao; S L Liu; X H Teng
Journal:  J Chromatogr B Biomed Appl       Date:  1996-06-07

10.  Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells.

Authors:  Martin Traebert; Bérengère Dumotier; Lothar Meister; Peter Hoffmann; Manuel Dominguez-Estevez; Willi Suter
Journal:  Eur J Pharmacol       Date:  2004-01-19       Impact factor: 4.432

View more
  4 in total

1.  Pharmacodynamic interaction between lumefantrine and desbutyl-benflumetol in Plasmodium falciparum in vitro.

Authors:  Alexander Leeb; Gunther Wernsdorfer; Wichai Satimai; Ursula Wiedermann; Kanungnit Congpuong; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2010-10       Impact factor: 1.704

2.  Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria.

Authors:  Sam Salman; Madhu Page-Sharp; Susan Griffin; Kaye Kose; Peter M Siba; Kenneth F Ilett; Ivo Mueller; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

3.  Desbutyl-lumefantrine is a metabolite of lumefantrine with potent in vitro antimalarial activity that may influence artemether-lumefantrine treatment outcome.

Authors:  Rina P M Wong; Sam Salman; Kenneth F Ilett; Peter M Siba; Ivo Mueller; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

4.  Interaction between lumefantrine and monodesbutyl-benflumetol in Plasmodium falciparum in vitro.

Authors:  Peter Starzengruber; Herwig Kollaritsch; Jeeraphat Sirichaisinthop; Gunther Wernsdorfer; Kanungnit Congpuong; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.